Urovant Sciences Ltd. Rings the Opening Bell
ABOUT THIS EVENT
Urovant Sciences Ltd. (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Keith Katkin, CEO, rang the Opening Bell.